Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 9,854 shares at $68.34 ($687K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Scheduled sale ($687k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.34 | 1,859 | $127K | 18.5% |
| 2 | $69.85 | 4,340 | $303K | 44.1% |
| 3 | $70.34 | 3,260 | $229K | 33.4% |
| 4 | $69.69 | 395 | $28K | 4.0% |
| Total | $69.72 avg | 9,854 | $687K | 100% |
| Filing → |
| ORKA | SELL | 2026-09-15 | $926K | — | Filing → |
| ORKA | SELL | 2026-08-14 | $1.1M | — | Filing → |
| ORKA | SELL | 2026-07-13 | $846K | — | Filing → |